<DOC>
	<DOC>NCT02593968</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of Yallaferon in Chinese population with HPV-16 and/or HPV-18.</brief_summary>
	<brief_title>Yallaferon in Chinese Population</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<criteria>Age 25 to 65 years of age the sex life of female patients; Highrisk HPV 16 and/or 18 positive Agree to sign ICF Cervical intraepithelial neoplasia (CIN); Combined with a severe fungal, trichomonas vaginitis; Severe primary diseases associated with cardiovascular, liver, kidney and hematopoietic system; Allergies or allergy to the drug known ingredients. Within 30 days to accept other clinical trials of drugs or are participating in clinical trials; Pregnant and lactating women and to be pregnant women; The researchers do not consider it appropriate clinical trials.</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>